Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors.
暂无分享,去创建一个
[1] V. Sondak,et al. Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene. , 1996, Human gene therapy.
[2] R. Ashmun,et al. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. , 1989, The Journal of clinical investigation.
[3] R. Jackman,et al. Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. , 1994, Circulation research.
[4] S. Riddell,et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. , 1992, Science.
[5] C F Dewey,et al. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Zeng,et al. Kinetic, dynamic, and pathway studies of glycerol metabolism by Klebsiella pneumoniae in anaerobic continuous culture: III. Enzymes and fluxes of glycerol dissimilation and 1,3-propanediol formation. , 1998, Biotechnology and bioengineering.
[7] E. Papoutsakis,et al. Sparging and agitation‐induced injury of cultured animals cells: Do cell‐to‐bubble interactions in the bulk liquid injure cells? , 2000, Biotechnology and bioengineering.
[8] S. Izumo,et al. Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] J G Bender,et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. , 1996, Blood.
[10] D. L. Liu,et al. Repeated immunotherapy using intratumoural injection with recombinant interleukin-2 and tumour-infiltrating lymphocytes inhibits growth of breast cancer and induces apoptosis of tumour cells. , 1996, Cancer letters.
[11] S. Rosenberg,et al. Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Arthur E. Humphrey,et al. Shake Flask to Fermentor: What Have We Learned? , 1998 .
[13] M. Papadaki,et al. Effects of Fluid Shear Stress on Gene Regulation of Vascular Cells , 1997, Biotechnology progress.
[14] W M Miller,et al. Hematopoietic cell culture therapies (Part II): Clinical aspects and applications. , 1996, Trends in biotechnology.
[15] S. Riddell,et al. CD8+ cytotoxic T cell therapy of cytomegalovirus and HIV infection. , 1993, Current opinion in immunology.
[16] M. Al‐Rubeai,et al. Cell cycle and cell size dependence of susceptibility to hydrodynamic forces. , 1995, Biotechnology and bioengineering.
[17] P. Pedrazzoli,et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. , 1997, Blood.
[18] T. Tsuruo,et al. Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation , 1993, International journal of cancer.
[19] J. Langner,et al. Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma , 1994, Immunology Letters.
[20] Bernhard O. Palsson,et al. Large-scale Expansion of Human Stem and Progenitor Cells From Bone Marrow Mononuclear Cells in Continuous Perfusion Cultures , 1993 .
[21] S Chien,et al. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Hoffmann,et al. Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequences , 1993, FEBS letters.
[23] H. Wakimoto,et al. In vivo antitumor effect of cytotoxic T lymphocytes engineered to produce interferon-gamma by adenovirus-mediated genetic transduction. , 1996, Biochemical and biophysical research communications.
[24] E. Papoutsakis,et al. Fluid‐mechanical forces in agitated bioreactors reduce the CD13 and CD33 surface protein content of HL60 cells , 1993, Biotechnology and bioengineering.
[25] C. Verfaillie,et al. Expansion and activation of human natural killer cells for autologous therapy. , 1994, Journal of hematotherapy.
[26] Alvin W. Nienow,et al. The effects of agitation intensity with and without continuous sparging on the growth and antibody production of hybridoma cells , 1989 .
[27] S. Diamond,et al. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress , 1990, Journal of cellular physiology.
[28] M. Al‐Rubeai,et al. Death mechanisms of animal cells in conditions of intensive agitation , 1995, Biotechnology and bioengineering.
[29] M. Roussel,et al. Molecular cloning, expression, and chromosomal localization of the gene encoding a human myeloid membrane antigen (gp150). , 1986, The Journal of clinical investigation.
[30] S. Rosenberg,et al. The Development of Gene Therapy for the Treatment of Cancer , 1993, Annals of surgery.
[31] J. Miller,et al. Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor. , 1996, Journal of hematotherapy.
[32] S. Rosenberg,et al. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. , 1995, Journal of immunology.
[33] A Sette,et al. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. , 1995, Journal of immunology.
[34] Malcolm K. Brenner,et al. Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.
[35] S. Riddell,et al. Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington , 1992 .
[36] E. Papoutsakis,et al. Damaging agitation intensities increase DNA synthesis rate and alter cell‐cycle phase distributions of CHO cells , 1992, Biotechnology and bioengineering.
[37] P. Davies,et al. Flow-mediated endothelial mechanotransduction. , 1995, Physiological reviews.
[38] E. Papoutsakis,et al. Ex vivo culture systems for hematopoietic cells. , 1996, Current opinion in biotechnology.
[39] M. Peshwa,et al. Generation and ex vivo expansion of HTLV‐1 specific CD8+ cytotoxic T‐lymphocytes for adoptive immunotherapy , 2000, Biotechnology and bioengineering.
[40] W M Miller,et al. Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. , 1998, Biotechnology and bioengineering.
[41] S. Rosenberg,et al. Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy. , 1987, Journal of immunological methods.
[42] E. Papoutsakis,et al. Fluid-mechanical damage of animal cells in bioreactors. , 1991, Trends in biotechnology.
[43] M. Al‐Rubeai,et al. A flow cytometric study of hydrodynamic damage to mammalian cells. , 1993, Journal of biotechnology.
[44] J. Olsen,et al. Cloning of the pig aminopeptidase N gene , 1989, FEBS letters.
[45] P. Greenfield,et al. Mechanical agitation of hybridoma suspension cultures: Metabolic effects of serum, pluronic F68, and albumin supplements , 1992, Biotechnology and bioengineering.
[46] P. Crocker,et al. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. , 1995, Blood.
[47] W M Miller,et al. Characterization of Hematopoietic Cell Expansion, Oxygen Uptake, and Glycolysis in a Controlled, Stirred‐Tank Bioreactor System , 1998, Biotechnology progress.
[48] F. Kargı,et al. Biological responses of hybridoma cells to hydrodynamic shear in an agitated bioreactor. , 1991, Enzyme and microbial technology.
[49] S. Riddell,et al. Principles for adoptive T cell therapy of human viral diseases. , 1995, Annual review of immunology.
[50] Jiahuai Han,et al. The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.